ONCT
NASDAQ
$0.53
Oncternal Therapeutics Inc (ONCT)
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of cancer therapies for cancers with critical unmet medical needs. The company is headquartered in San Diego, California.
Sector:
Healthcare
Industry:
Biotechnology
Target: $2 (+279.79%)
Market Cap
$1.56M
P/B Ratio
0.17
Price Chart
Valuation
Market Cap$1.56M
P/S0.72
P/B0.17
Profitability
Total Revenue (TTM)$2.16M
Gross Profit (TTM)-$6.51M
EBITDA-$36M
Operating Margin-1757%
EPS-$11.70
Growth & Risk
Sharpe Ratio-0.73